Soft Targets: Nurses and the Pharmaceutical Industry


article has not abstract


Vyšlo v časopise: Soft Targets: Nurses and the Pharmaceutical Industry. PLoS Med 5(2): e5. doi:10.1371/journal.pmed.0050005
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.0050005

Souhrn

article has not abstract


Zdroje

1. Nursing Standard

2007

‘Special projects’ sponsorship.

Available: http://www.nursing-standard.co.uk/advertising/specprods.asp. Accessed 27 December 2007

2. BurnsD

2002

Nurse prescribing. Nurses' influence on GPs' prescribing.

Nurs Times

98

41

42

3. MansfieldPRMintzesBRichardsDToopL

2005

Direct to consumer advertising.

BMJ

330

5

6

4. MansfieldPRMintzesB

2003

Direct-to-consumer advertising is more profitable if it is misleading.

N Z Med J

116

U610

5. MintzesBBarerMLKravitzRLKazanjianABassettK

2002

Influence of direct-to-consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.

BMJ

324

278

279

6. HealyD

2006

The latest mania: Selling bipolar disorder.

PLoS Med

3

e185

doi:10.1371/journal.pmed.0030185

7. WazanaA

2000

Physicians and the pharmaceutical industry. Is a gift ever just a gift.

JAMA

283

373

380

8. SmithR

2003

Medical journals and pharmaceutical companies: uneasy bedfellows.

BMJ

326

1202

1205

9. SmithR

2002

Making progress with competing interests—still some way to go.

BMJ

325

1375

1376

10. BakerCJohnsrudMTCrismonMRosenheckRAWoodsSW

2003

Quantitative analysis of sponsorship bias in economic studies of antidepressants.

Br J Psychiatry

183

498

506

11. BoydEABeroLA

2000

Assessing faculty financial relationships with industry: a case study.

JAMA

284

2209

2214

12. LexchinJBeroLADjulbegovicBClarkO

2003

Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

BMJ

326

1167

1176

13. MoncrieffJHopkerSThomasP

2005

Psychiatry and the pharmaceutical industry: who pays the piper.

Psych Bull

29

84

85

14. PerlisRHPerlisCSWuYHwangCJosephM

2005

Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.

Am J Psychiatry

162

1957

1960

15. WagerE

2003

How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.

BMJ

326

1196

1198

16. GøtzschePCHróbjartssonAJohansenHKHaahrMTAltmanDG

2007

Ghost authorship in industry-initiated randomised trials.

PLoS Med

4

e19

doi:10.1371/journal.pmed.0040019

17. MenkesDB

2006

Psychiatrist subscribing preferences and attitudes toward promotion.

Inaugural Conference on Disease-Mongering; 11–13 April 2006; Newcastle, Australia

18. AshmoreRCarverN

2001

The pharmaceutical industry and mental health nursing.

Br J Nurs

10

1396

1402

19. MahonS

2006

Impact of direct-to-consumer advertising on healthcare providers and consumers.

Clin J Oncol Nurs

10

417

420

20. VialePH

2003

What nurse practitioners should know about direct-to-consumer advertising of prescription medications.

J Am Acad Nurse Pract

15

297

304

21. InlanderC

1991

A hard pill to swallow. Advertising prescription drugs directly to the consumer.

Nurs Econ

9

343

347

22. GruberWLlewelynJArrasCLionS

1995

The role of the pharmaceutical industry in promoting patient education.

Patient Educ Couns

26

245

249

23. VialePH

2002

Direct-to-consumer advertising of prescription medications: implications for patients with cancer.

Oncol Nurs Forum

29

505

513

24. VialePHYamamotoDS

2004

The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.

Oncol Nurs Forum

31

777

783

25. BowronA

2006

Bridging the information gap in primary care.

Community Pract

79

242

26. DaviesJHemingwayS

2006

Pharmaceutical influences: nurse prescribers: eyes wide open.

Nurse Prescr

1

e42

27. DeSiletsLD

2006

Commercial support for professional development.

J Contin Educ Nurs

37

52

53

28. EdmundsM

2004

Confusing ethical guidelines dampen pharmaceutical support.

Nurse Pract

29

16

29. FlewellMN

2006

Pharmaceutical sales reps: Value beyond samples.

Adv Nurse Pract

14

18

30. HallJCantrillJNoyceP

2003

The information sources used by community nurse prescribers.

Br J Nurs

12

810

818

31. KessenichCRWestbrookMH

1999

Pharmaceutical companies and the prescriptive practices of nurse practitioners.

J Am Acad Nurse Pract

11

533

538

32. MonaghanMSGaltKATurnerPDHoughtonBLRichEC

2003

Student understanding of the relationship between the health professions and the pharmaceutical industry.

Teaching and learning in medicine

15

14

20

33. NolanPCarrNDoranM

2004

Nurse prescribing: The experiences of psychiatric nurses in the United States.

Nurs Stand

18

33

38

34. YoungM

2006

They are more than just pretty people handing out cool pens.

Dermatol Nurs

18

323

324

35. KleinCA

2006

Dispensing pharmaceutical samples: A few reminders.

Nurse Pract

31

15

36. Alexander-BanysB

2002

Pharmaceutical company advertising practices: Call to arms.

J Pediatr Health Care

16

49

50

37. SidiqiSEdmundsM

2003

Pharmaceutical influence.

Nurse Pract

28

6

7

38. EdmundsM

2003

Response to Sidiqi.

Nurse Pract

28

7

39. O'MalleyP

2006

Pharmaceutical advertising and clinical nurse specialist practice.

Clin Nurse Spec

20

13

15

40. AshmoreRCarverNBanksD

2007

Mental health nursing students' relationships with the pharmaceutical industry.

Nurse Educ Today

27

551

560

41. WillisJ

1997

The drug squad.

Nurs Times

93

36

38

42. DayL

2006

Industry gifts to healthcare providers: are the concerns serious.

Am J Crit Care

5

510

513

43. LieferD

1997

Warning over drug courses.

Nurs Stand

11

9

44. KmietowiczZ

2004

Drug company influence extends to nurses, pharmacists and patient groups.

BMJ

329

1206

45. CriggerNJBennisonJW

2006

Unethical marketing or business as usual.

Adv Nurse Pract

15

61

68

46. HemingwayS

2003

Mental health nursing and the pharmaceutical industry.

Ment Health Pract

7

22

23

47. CastledineG

2003

Nurses must be immune to product promotions.

Br J Nurs

12

827

48. StokamerCI

2003

Pharmaceutical gift giving: Analysis of an ethical dilemma.

J Nurs Adm

33

48

51

49. CriggerNJ

2005

Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: The undiscovered country.

J Am Acad Nurse Pract

17

207

212

50. International Committee of Medical Journal Editors

2007

Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication.

Available: http://www.icmje.org/index.html. Accessed 27 December 2007

51. MansfieldPRLexchinJWenLSGrandoriLMcCoyCP

2006

Educating health professionals about drug and device promotion: Advocates' recommendations.

PLoS Med

3

e451

doi:10.1371/journal.pmed.0030451

52. MenkesDB

2006

Calling the piper's tune.

Prim Care Clin Psychiatry

11

147

149

53. CardarelliRLicciardoneJCTaylorLG

2006

A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true.

BMC Fam Pract

7

13

54. ZieglerMLewPSingerB

1995

The accuracy of drug information from pharmaceutical sales representatives.

JAMA

273

1296

1298

55. CooperRJSchrigerDLWallaceRCMikulichVJWilkesMS

2003

The quantity and quality of scientific graphs in pharmaceutical advertisements.

J Gen Intern Med

18

294

297

56. KaphingstKADeJongW

2004

Market watch: The educational potential of direct-to-consumer prescription drug advertising.

Health Aff

23

143

150

57. MadhavanSAmonkarMMElliotDBurkeKGoreP

1997

The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians.

J Clin Pharm Ther

22

207

215

58. SteinmanMShlipakMMcPheeSJ

2001

Of principles and pens; attitudes and practices of medicine house staff toward pharmaceutical industry promotions.

Am J Med

551

557

59. WatkinsRSKimberlyJJr

2004

What residents don't know about physician-pharmaceutical industry interactions.

Acad Med

79

432

437

60. EmanuelEJEmanuelLL

1992

Four models of the physician-patient relationship.

JAMA

267

2221

2226

61. MansfieldPR

2007

Is it insulting to suggest that health professionals are influenced by drug companies.

Available: http://www.healthyskepticism.org/news/2007/May.php. Accessed 27 December 2007

62. Stanford University

2006

Policy and guidelines for interactions between the Stanford University School of Medicine, the Stanford Hospital and Clinics and Lucile Packard Children's Hospital with the pharmaceutical, bioetch, medical device, and hospital and research and supplies industries (“Industry”).

Available: http://med.stanford.edu/coi/siip/documents/siip_policy_aug06. pdf. Accessed 27 December 2007

63. JonesM

2004

Case Report. Nurse prescribing, a case study in policy influence.

Journal of nursing management

12

266

272

64. MittmanDEYackerenTFHendrixPMirotznikHG

1994

Sales reps recognize value of nurse practitioners.

Med Mark Media

29

52

54

65. ArnoldM

2004

The hidden prescribers.

Med Mark Media

39

44

52

66. WhileAEBiggsKS

2004

Benefits and challenges of nurse prescribing.

J Adv Nurs

45

559

567

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2008 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa